Skip to main content
Fig. 1 | Renal Replacement Therapy

Fig. 1

From: Novel double-filtration plasmapheresis preserves fibrinogen while removing immunoglobulin-G antibodies before ABO blood type-incompatible kidney transplantation

Fig. 1

Protocol for DFPP. As the plasma separator (primary membrane), Plasmaflo OP-08W was used in cDFPP and Cascadeflo EC-50W was used in nDFPP. Large molecules were removed from plasma using a secondary plasma fractionator (secondary membrane), Cascadeflo EC-20W, in both DFPP modalities. Albumin solution was used as replacement fluid and was infused at the same rate as the drain pump

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us